共 125 条
[1]
Ferlay J(2010)Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 Int J Cancer 127 2893-917
[2]
Shin H(2013)Cancer statistics, 2013 CA Cancer J Clin 63 11-30
[3]
Bray F(2010)Estrogen receptor mutations and changes in downstream gene expression and signaling Clin Cancer Res 16 2702-8
[4]
Forman D(2003)Breast cancer tissue estrogens and their manipulation with aromatase inhibitors and inactivators J Steroid Biochem Mol Biol 86 245-53
[5]
Mathers C(2005)Steroid sulfatase: molecular biology, regulation, and inhibition Endocr Rev 26 171-202
[6]
Parkin DM(1987)Use of the aromatase inhibitor 4-hydroxyandrostenedione in postmenopausal breast cancer: optimization of therapeutic dose and route Cancer Res 47 1957-61
[7]
Siegel R(1984)In situ estrogen production via the estrone sulfatase pathway in breast tumors: relative importance versus the aromatase pathway J Clin Endocrinol Metab 59 29-33
[8]
Naishadham D(1990)Effect of treatment with 4-hydroxyandrostenedione on the peripheral conversion of androstenedione to estrone and in vitro tumor aromatase activity in postmenopausal women with breast cancer Cancer Res 50 193-6
[9]
Jemal A(1981)The plasma concentration of oestrone sulphate in postmenopausal women: lack of diurnal variation, effect of ovariectomy, age and weight J Steroid Biochem 14 1101-5
[10]
Barone I(1994)The hydrolysis of oestrone sulphate and dehydroepiandrosterone sulphate by human steroid sulphatase expressed in transfected COS-1 cells J Steroid Biochem Mol Biol 50 101-4